Electronic Prior Authorization Enables “Clinically Appropriate” Prescribing, Market Researcher Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Automating prior authorization would be useful for drug classes, such as COX-2s and proton pump inhibitors, where coverage varies widely, MediMedia says. The firm maintains that implementation would be less complex than PBMs have asserted.